Broadleaf Partners »

United Therapeutics Corporation shares owned by Broadleaf Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Broadleaf Partners from 13F filings

Historical chart of Broadleaf Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Broadleaf Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Broadleaf Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.4M 9.7k 352.84
2024-09-30 $3.5M 9.7k 358.35

More positions owned by Broadleaf Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Schwab International Equity Et Etf (SCHF)
Servicenow (NOW)
Arista Networks
Intuitive Surgical (ISRG)
Schwab Us Large Cap Growth Etf Etf (SCHG)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Chipotle Mexican Grill (CMG)
Trade Desk (TTD)

View all positions for Broadleaf Partners

Top funds holding United Therapeutics Corporation

Wealthfront Advisers
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
State Street Corporation
Renaissance Technologies
FMR
Geode Capital Management
AQR Capital Management
LSV Asset Management
Alliancebernstein
Dimensional Fund Advisors
Pacer Advisors
Arrowstreet Capital, Limited Partnership

View all funds holding United Therapeutics Corporation